Huasun ขยายการดำเนินงานในเอเชียตะวันออกเฉียงใต้ด้วยการจัดส่งโมดูล Himalaya PLUS ขนาด 13.7 เมกะวัตต์สำหรับโครงการในเมียนมาร์by BangkokStyle28/08/2026PR Newswire (category)
Ulike Brings “Future Beauty, Powered by Light” to Boston, Challenging the Conventional Beauty Trade-Off Between Efficacy and Comfortby BangkokStyle28/08/2026PR Newswire (category)
Leifras Celebrates 25th Anniversary, Setting Vision for Becoming Global Infrastructure Through “Sports and Social”by BangkokStyle28/08/2026PR Newswire (category)
KLN Delivers Sustained Growth in Revenue and Core Net Profitby BangkokStyle28/08/2026PR Newswire (category)
SmallRig Technology Announces Completion of Acquisition of Selected Assets of Kelvin Groupby BangkokStyle28/08/2026PR Newswire (category)
Luxshare Precision Expects Net Profit to Rise 15%-25% in the First Nine Months of 2026by BangkokStyle28/08/2026PR Newswire (category)
Tineco Brings Next-Generation Floor Care Innovations at IFA 2026by BangkokStyle28/08/2026PR Newswire (category)
Global Tier-1 YFORE Rolls Off First U.S.-Built Digital Keyby BangkokStyle28/08/2026PR Newswire (category)
SuperX Secures First Batch of 128 Units of NVIDIA B300 AI Server Purchase Order from Ezisight, Marking Its Official Entry into the Australian Marketby BangkokStyle28/08/2026PR Newswire (category)
Fireblocks Sets Sights on Next Phase of Tokenization: NYSE Content Updateby BangkokStyle28/08/2026PR Newswire (category)
Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offeringby BangkokStyle28/08/2026PR Newswire (category)
Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharmaby BangkokStyle28/08/2026PR Newswire (category)
HiRO and Differentia Biotech Forge Strategic Alliance to Redefine Clinical Trial Design Through AI-Powered Simulationby BangkokStyle28/08/2026PR Newswire (category)
Formosa Pharmaceuticals Files Clinical Trial Application for TSY-110, an Antibody-Drug Conjugate Biosimilar Targeting HER2-Positive Breast Cancersby BangkokStyle28/08/2026PR Newswire (category)
